Đang chuẩn bị liên kết để tải về tài liệu:
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Treatment with tumor-Infiltrating Lymphocytes (TIL) is an innovative therapy for advanced melanoma with promising clinical phase I/II study results and likely beneficial cost-effectiveness. As a randomized controlled trial on the effectiveness of TIL therapy in advanced melanoma compared to ipilimumab is still ongoing, adoption of TIL therapy by the field is confronted with uncertainty. |

TÀI LIỆU LIÊN QUAN

Báo cáo khoa học: "Different Structures for Evaluating Answers to Complex Questions: Pyramids Won’t Topple, and Neither Will Human Assessors"

Evaluating the efficiency of microbes in mung bean by different tests for improving crop yields

Application of the AHP and TOPSIS in project management

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

Evaluating pathogenic diversity of seven isolates of Xanthomonas oryzae pv oryzae derived from different hotspot of Chhattisgarh on near isogenic lines (NILs)

Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells

Evaluating different breast tumor progression models using screening data

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

Evaluating non-responders of a survey in the Swedish fracture register: No indication of different functional result